Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure - Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure

Description:

The goal of the trial was to evaluate treatment with spironolactone in addition to an angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin-receptor blocker (ARB) among patients with chronic renal disease.